Table 4

Correlates of the number of high dose (>90 daily OME) opioid prescriptions

CirrhosisHepatitis C without cirrhosis
Mean # high dose prescriptionsRR95% CIP valueMean # high dose prescriptionsRR95% CIP value
Age (years)
 ≤184.40.460.37 to 0.57<0.0014.60.350.29 to 0.41<0.001
 19–396.81.201.12 to 1.28<0.0016.61.071.00 to 1.140.051
 40–598.51.321.27 to 1.37<0.00110.01.171.11 to 1.23<0.001
 ≥605.11.00Reference6.61.00Reference
Sex
 Male7.61.261.21 to 1.30<0.0019.31.301.26 to 1.35<0.001
 Female7.21.00Reference8.51.00Reference
Geographic region
 Northeast8.20.930.87 to 0.980.00810.00.840.79 to 0.89<0.001
 North Central6.80.710.67 to 0.75<0.0018.30.690.65 to 0.73<0.001
 South6.80.650.62 to 0.69<0.0018.10.700.67 to 0.74<0.001
 West8.71.00Reference10.11.00Reference
Substance abuse/mental health diagnosis
 Yes9.61.291.24 to 1.35<0.00110.81.621.55 to 1.69<0.001
 No6.61.00Reference8.11.00Reference
Charlson comorbidity index
 2 or higher7.31.251.20 to 1.29<0.0019.81.131.08 to 1.19<0.001
 0–17.51.00Reference8.81.00Reference
Aetiology of liver diseaseN/A
 Alcoholic cirrhosis with HCV9.71.251.17 to 1.33<0.001
 Alcoholic cirrhosis (without HCV)7.20.980.93 to 1.030.353
 HCV cirrhosis (without alcohol)9.41.191.13 to 1.25<0.001
 Other cirrhosis*6.31.00Reference
  • *Includes all forms of cirrhosis excluding HCV and alcoholic related cirrhosis.

  • HCV, hepatitis C virus;N/A, not applicable; OME, opioid morphine equivalents; RR, relative risk.